biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by zwerp2000on Apr 26, 2021 2:45pm

131 Views

Post# 33068041

Chrispi/JD the stock is getting hammered again

Well, the end of the quarter came and went, eh? No data? No partnerships? Nothing on prothena. Presumably if something happened with prothena that was material, the company would have to announce it. The stock price is tanking. So what's the excuse this time? More delays, more of the company not doing what they said they'd do, more of nothing. How many years have you owned this garbage? JD continues to embarrass himself with his ridiculous commentary that has yet to come to fruition for years. This company js a joke

<< Previous

Bullboard Posts

Next >>

Full Circle Lithium goes global with its battery fire-fighter